The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…


Pfizer appeals record fine from U.K. regulator tied to 2,600% drug price hike

Pfizer, GSK targeted for vaccine pricing in MSF Twitter spree

Pfizer to close Australia plant, whack 89 jobs